{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:26:08Z","timestamp":1788297968980,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005933","name":"Camurus AB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005933","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jsat.2022.108781","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T11:01:36Z","timestamp":1649502096000},"page":"108781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Long-acting depot buprenorphine in people who are homeless: Views and experiences"],"prefix":"10.1016","volume":"139","author":[{"given":"Catriona","family":"Matheson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2022.108781_bb0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/02673037.2017.1344957","article-title":"Homelessness in the UK: Who is most at risk?","volume":"33","author":"Bramley","year":"2017","journal-title":"Housing Studies"},{"key":"10.1016\/j.jsat.2022.108781_bb0015","author":"Bramley"},{"key":"10.1016\/j.jsat.2022.108781_bb0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.habitatint.2016.03.004","article-title":"Developing a global framework for conceptualising and measuring homelessness","volume":"55","author":"Busch-Geertsema","year":"2016","journal-title":"Habitat International"},{"issue":"1","key":"10.1016\/j.jsat.2022.108781_bb0025","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1472-6963-12-222","article-title":"Service provision and barriers to care for homeless people with mental health problems across 14 European capital cities","volume":"12","author":"Canavan","year":"2012","journal-title":"BMC Health Services Research"},{"issue":"5","key":"10.1016\/j.jsat.2022.108781_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.therap.2020.05.007","article-title":"Prolonged-release buprenorphine formulations: Perspectives for clinical practice","volume":"75","author":"Chappuy","year":"2020","journal-title":"Therapie"},{"issue":"8","key":"10.1016\/j.jsat.2022.108781_bb0045","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.14636","article-title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder","volume":"114","author":"Frost","year":"2019","journal-title":"Addiction"},{"issue":"685","key":"10.1016\/j.jsat.2022.108781_bb0050","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.3399\/bjgp19X704633","article-title":"Provision and accessibility of primary healthcare services for people who are homeless: A qualitative study of patient perspectives in the UK","volume":"69","author":"Gunner","year":"2019","journal-title":"British Journal of General Practice"},{"issue":"8","key":"10.1016\/j.jsat.2022.108781_bb0060","first-page":"306","article-title":"Homelessness is a healthcare issue","volume":"103","author":"Hewett","year":"2010"},{"key":"10.1016\/j.jsat.2022.108781_bb0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amepre.2005.06.017","article-title":"Interventions to improve the health of the homeless: A systematic review","volume":"29","author":"Hwang","year":"2005","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.jsat.2022.108781_bb0080","author":"ISD"},{"key":"10.1016\/j.jsat.2022.108781_bb0085","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/add.14941","article-title":"Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia","volume":"115","author":"Larance","year":"2020","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.jsat.2022.108781_bb0095","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamainternmed.2018.1052","article-title":"Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial","volume":"178","author":"Lofwall","year":"2018","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2022.108781_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227298","article-title":"The effectiveness of substance use interventions for homeless and vulnerably housed persons: A systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder","volume":"15","author":"Magwood","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jsat.2022.108781_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugpo.2015.11.006","article-title":"Community pharmacy Services for People with drug problems over two decades in Scotland: Implications for future development","volume":"27","author":"Matheson","year":"2016","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2022.108781_bb0115","author":"McDonagh"},{"issue":"1","key":"10.1016\/j.jsat.2022.108781_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14616710802693607","article-title":"Agency, transgression and the causation of homelessness: A contextualised rational action analysis","volume":"9","author":"McNaughton-Nicholls","year":"2009","journal-title":"European Journal of Housing Policy"},{"issue":"5","key":"10.1016\/j.jsat.2022.108781_bb0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/dar.12939","article-title":"Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences","volume":"38","author":"Neale","year":"2019","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2022.108781_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108342","article-title":"Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting","volume":"127","author":"O'Gurek","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2022.108781_bb0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/SAR.S266838","article-title":"Patient-reported outcomes, experiences and satisfaction with weekly and monthly injectable prolonged-release buprenorphine","volume":"11","author":"Parsons","year":"2020","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.jsat.2022.108781_bb0145","first-page":"10","article-title":"Word on the street: homelessness and pharmacists","author":"Pathway","year":"2017","journal-title":"Wales Pharmacy Review"},{"key":"10.1016\/j.jsat.2022.108781_bb0150","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/jan.12675","article-title":"The perceptions of homeless people regarding their healthcare needs and experiences of receiving health care","volume":"71","author":"Rae","year":"2015","journal-title":"Journal of Advanced Nursing"},{"key":"10.1016\/j.jsat.2022.108781_bb0300","series-title":"Qualitative research practice\u2014A guide for social science students and researchers","author":"Ritchie","year":"2003"},{"key":"10.1016\/j.jsat.2022.108781_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jsat.2022.108781_bb0165","author":"Thomas"},{"key":"10.1016\/j.jsat.2022.108781_bb0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2019.06.007","article-title":"Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder","volume":"104","author":"Tompkins","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1016\/j.jsat.2022.108781_bb0175","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/17425247.2019.1649252","article-title":"What place for prolonged-release buprenorphine depot-formulation Buvidal\u00ae in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine","volume":"16","author":"Vorspan","year":"2019","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.jsat.2022.108781_bb0180","author":"Walsh"},{"key":"10.1016\/j.jsat.2022.108781_bb0185","series-title":"Valuing control over one'\u2019s immediate living environment: How homelessness responses corrode capabilities","author":"Watts","year":"2021"},{"key":"10.1016\/j.jsat.2022.108781_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/01612840.2012.757402","article-title":"Hearing the silent voices: Narratives of health care and homelessness","volume":"34","author":"Wise","year":"2013","journal-title":"Issues in Mental Health Nursing"},{"issue":"525","key":"10.1016\/j.jsat.2022.108781_bb0195","first-page":"286","article-title":"How can health services effectively meet the health needs of homeless people?","volume":"56","author":"Wright","year":"2006","journal-title":"British Journal of General Practice"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547222000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:42Z","timestamp":1760039862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547222000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"alternative-id":["S0740547222000630"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108781","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting depot buprenorphine in people who are homeless: Views and experiences","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2022.108781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108781"}}